Entities / Company
Molecular Partners.
biopharmaceutical company based in Zürich, Switzerland
- Reports this week
- 0
- Active events
- 0
- Connections
- 13
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
One to three months ago
Gone quiet
No new reports in 90+ days-
Analyst firm TD Cowen issued buy ratings for Molecular Partners, a company based in Switzerland.Some support2 reports
-
Molecular Partners and Orano Med formed a strategic partnership to co-develop the MP0726 candidate.Speculative1 report
-
Molecular Partners announced Patrick Amstutz as CEO, detailing the career background of Martin Steegmaier, including his previous roles at Roche, MorphoSys, and Boehringer Ingelheim.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around Molecular Partners this week
News at the entities that move Molecular Partners most-
TD Cowen Mentioned togetherJim Cramer commented on L3Harris Technologies stock valuation as Goldman Sachs and TD Cowen cut price targets.Moves Molecular Partners
-
Switzerland Shared contextIran institutes a militia system modeled after Switzerland and sanctions are lifted, enabling trade and relations.Moves Molecular Partners
-
Zurich Shared contextA water summit is being held in Zurich to address major challenges facing the water sector across Europe.Moves Molecular Partners
Connections
The 5 strongest of 13, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Patrick Amstutz Structural
Patrick Amstutz holds the role of CEO for Molecular Partners.
-
TD Cowen Mentioned together
TD Cowen provides analyst coverage and buy ratings for Molecular Partners.
-
Switzerland Shared context
Molecular Partners is identified as a biotech company operating within Switzerland.
-
Zurich Shared context
Molecular Partners operates from its offices and headquarters located in the city of Zurich.
-
Concord Shared context
Molecular Partners maintains offices and operations within Concord, MA.
History
Events by the month they beganAugust 2026
1 eventJune 2026
3 events- Analyst firm TD Cowen issued buy ratings for Molecular Partners, a company based in Switzerland.
- Molecular Partners and Orano Med formed a strategic partnership to co-develop the MP0726 candidate.
- Molecular Partners announced Patrick Amstutz as CEO, detailing the career background of Martin Steegmaier, including his previous roles at Roche, MorphoSys, and Boehringer Ingelheim.